H.B. Fuller (NYSE:FUL) VP Nathan D. Weaver sold 6,622 shares of the business’s stock in a transaction that occurred on Monday, April 5th. The shares were sold at an average price of $64.13, for a total transaction of $424,668.86. Following the completion of the transaction, the vice president now owns 10,239 shares of the company’s stock, valued at $656,627.07. The sale was disclosed in a legal filing with the SEC, which is available at this link.
H.B. Fuller stock opened at $62.92 on Thursday. The business has a 50 day moving average of $59.82 and a 200-day moving average of $53.55. The company has a market capitalization of $3.29 billion, a P/E ratio of 28.60, a P/E/G ratio of 2.10 and a beta of 1.72. H.B. Fuller has a 1 year low of $28.35 and a 1 year high of $64.99. The company has a debt-to-equity ratio of 1.41, a current ratio of 2.17 and a quick ratio of 1.39.
H.B. Fuller (NYSE:FUL) last posted its earnings results on Tuesday, March 23rd. The specialty chemicals company reported $0.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.19. The firm had revenue of $725.90 million for the quarter, compared to analyst estimates of $680.98 million. H.B. Fuller had a net margin of 4.19% and a return on equity of 11.18%. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.34 EPS. Equities analysts anticipate that H.B. Fuller will post 2.64 EPS for the current year.
Institutional investors and hedge funds have recently made changes to their positions in the business. California State Teachers Retirement System increased its stake in shares of H.B. Fuller by 0.5% in the third quarter. California State Teachers Retirement System now owns 77,825 shares of the specialty chemicals company’s stock valued at $3,563,000 after buying an additional 411 shares during the period. Nisa Investment Advisors LLC increased its position in H.B. Fuller by 2.0% during the 4th quarter. Nisa Investment Advisors LLC now owns 24,525 shares of the specialty chemicals company’s stock valued at $1,272,000 after purchasing an additional 480 shares during the period. Dorsey & Whitney Trust CO LLC raised its holdings in H.B. Fuller by 5.2% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 63,165 shares of the specialty chemicals company’s stock worth $3,277,000 after purchasing an additional 3,111 shares during the last quarter. UBS Asset Management Americas Inc. lifted its position in shares of H.B. Fuller by 5.7% in the 3rd quarter. UBS Asset Management Americas Inc. now owns 66,801 shares of the specialty chemicals company’s stock worth $3,058,000 after purchasing an additional 3,614 shares during the period. Finally, Panagora Asset Management Inc. boosted its stake in shares of H.B. Fuller by 351.9% in the 4th quarter. Panagora Asset Management Inc. now owns 5,784 shares of the specialty chemicals company’s stock valued at $300,000 after purchasing an additional 4,504 shares during the last quarter. 95.42% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages recently issued reports on FUL. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of H.B. Fuller from $56.00 to $65.00 and gave the company a “hold” rating in a research note on Monday, March 29th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised H.B. Fuller from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $50.00 to $61.00 in a report on Friday, December 18th. Smith Barney Citigroup reiterated a “neutral” rating on shares of H.B. Fuller in a research note on Friday, December 18th. Robert W. Baird increased their target price on shares of H.B. Fuller from $65.00 to $72.00 and gave the stock an “outperform” rating in a report on Friday, March 26th. They noted that the move was a valuation call. Finally, Zacks Investment Research raised shares of H.B. Fuller from a “hold” rating to a “buy” rating and set a $71.00 price target on the stock in a report on Tuesday, March 30th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. H.B. Fuller has a consensus rating of “Buy” and a consensus price target of $57.57.
H.B. Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Recommended Story: Monthly Dividend Stocks Can Provide Solid Income
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.